Literature DB >> 25542864

Alex's Lemonade Stand Foundation Infant and Childhood Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2007-2011.

Quinn T Ostrom1, Peter M de Blank2, Carol Kruchko3, Claire M Petersen4, Peter Liao5, Jonathan L Finlay6, Duncan S Stearns2, Johannes E Wolff7, Yingli Wolinsky1, John J Letterio2, Jill S Barnholtz-Sloan1.   

Abstract

The CBTRUS Statistical Report: Alex's Lemonade Stand Foundation Infant and Childhood Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2007–2011 comprehensively describes the current population-based incidence of primary malignant and non-malignant brain and CNS tumors in children ages 0–14 years, collected and reported by central cancer registries covering approximately 99.8% of the United States population (for 2011 only, data were available for 50 out of 51 registries). Overall, brain and CNS tumors are the most common solid tumor, the most common cancer, and the most common cause of cancer death in infants and children 0–14 years. This report aims to serve as a useful resource for researchers, clinicians, patients, and families.

Entities:  

Mesh:

Year:  2015        PMID: 25542864      PMCID: PMC4277295          DOI: 10.1093/neuonc/nou327

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN: 1522-8517            Impact factor:   12.300


  4 in total

1.  International Classification of Childhood Cancer, third edition.

Authors:  Eva Steliarova-Foucher; Charles Stiller; Brigitte Lacour; Peter Kaatsch
Journal:  Cancer       Date:  2005-04-01       Impact factor: 6.860

2.  CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007-2011.

Authors:  Quinn T Ostrom; Haley Gittleman; Peter Liao; Chaturia Rouse; Yanwen Chen; Jacqueline Dowling; Yingli Wolinsky; Carol Kruchko; Jill Barnholtz-Sloan
Journal:  Neuro Oncol       Date:  2014-10       Impact factor: 12.300

Review 3.  Consensus Conference on Brain Tumor Definition for registration. November 10, 2000.

Authors:  Bridget J McCarthy; Tanya Surawicz; Janet M Bruner; Carol Kruchko; Faith Davis
Journal:  Neuro Oncol       Date:  2002-04       Impact factor: 12.300

4.  Efficient interval estimation for age-adjusted cancer rates.

Authors:  Ram C Tiwari; Limin X Clegg; Zhaohui Zou
Journal:  Stat Methods Med Res       Date:  2006-12       Impact factor: 3.021

  4 in total
  168 in total

Review 1.  Visual function in children with primary brain tumors.

Authors:  Jason H Peragallo
Journal:  Curr Opin Neurol       Date:  2019-02       Impact factor: 5.710

2.  CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2008-2012.

Authors:  Quinn T Ostrom; Haley Gittleman; Jordonna Fulop; Max Liu; Rachel Blanda; Courtney Kromer; Yingli Wolinsky; Carol Kruchko; Jill S Barnholtz-Sloan
Journal:  Neuro Oncol       Date:  2015-10-27       Impact factor: 12.300

3.  American Brain Tumor Association Adolescent and Young Adult Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2008-2012.

Authors:  Quinn T Ostrom; Haley Gittleman; Peter M de Blank; Jonathan L Finlay; James G Gurney; Roberta McKean-Cowdin; Duncan S Stearns; Johannes E Wolff; Max Liu; Yingli Wolinsky; Carol Kruchko; Jill S Barnholtz-Sloan
Journal:  Neuro Oncol       Date:  2016-01       Impact factor: 12.300

4.  Loss of CDKN1C in a Recurrent Atypical Teratoid/Rhabdoid Tumor.

Authors:  Dustin Tran; Sandra Camelo-Piragua; Avneesh Gupta; Kate Gowans; Patricia L Robertson; Rajen Mody; Carl Koschmann
Journal:  J Pediatr Hematol Oncol       Date:  2017-11       Impact factor: 1.289

5.  Differences in molecular profiles of glioblastomas according to location.

Authors:  Craig Horbinski
Journal:  Neuro Oncol       Date:  2019-01-01       Impact factor: 12.300

Review 6.  CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2011-2015.

Authors:  Quinn T Ostrom; Haley Gittleman; Gabrielle Truitt; Alexander Boscia; Carol Kruchko; Jill S Barnholtz-Sloan
Journal:  Neuro Oncol       Date:  2018-10-01       Impact factor: 12.300

7.  Rationale and Design of a Phase 1 Clinical Trial to Evaluate HSV G207 Alone or with a Single Radiation Dose in Children with Progressive or Recurrent Malignant Supratentorial Brain Tumors.

Authors:  Alicia M Waters; James M Johnston; Alyssa T Reddy; John Fiveash; Avi Madan-Swain; Kara Kachurak; Asim K Bag; G Yancey Gillespie; James M Markert; Gregory K Friedman
Journal:  Hum Gene Ther Clin Dev       Date:  2017-03       Impact factor: 5.032

8.  Multimodal treatments combined with gamma knife surgery for primary atypical teratoid/rhabdoid tumor of the central nervous system: a single-institute experience of 18 patients.

Authors:  Yan-Ming Ren; Xia Wu; Chao You; Yue-Kang Zhang; Qiang Li; Yan Ju
Journal:  Childs Nerv Syst       Date:  2017-12-07       Impact factor: 1.475

9.  Racial and ethnic differences in survival of pediatric patients with brain and central nervous system cancer in the United States.

Authors:  David A Siegel; Jun Li; Helen Ding; Simple D Singh; Jessica B King; Lori A Pollack
Journal:  Pediatr Blood Cancer       Date:  2018-10-23       Impact factor: 3.167

Review 10.  Proton therapy for paediatric CNS tumours - improving treatment-related outcomes.

Authors:  Vinai Gondi; Torunn I Yock; Minesh P Mehta
Journal:  Nat Rev Neurol       Date:  2016-05-20       Impact factor: 42.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.